Benjamin J. Davies

Benjamin Davies practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Benjamin Davies' NPI, 1831200401, was assigned on August 31, 2006. Benjamin Davies graduated from Icahn School Of Medicine At Mount Sinai in 2000. Benjamin Davies holds California license A94247.

Benjamin Davies' primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Benjamin Davies' primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Benjamin Davies is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Benjamin Davies to 5 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Benjamin Davies practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Benjamin Davies' primary specialty in the NPI Registry, under taxonomy code 208800000X. Benjamin Davies is board certified in urology by the American Board of Urology. Dmand AI has Benjamin Davies' licenses on file in 3 states: California, Pennsylvania and Florida.

Dmand AI lists bladder removal, enlarged prostate, kidney cysts, kidney removal surgery, prostate cancer, prostate surgery and urinary endoscopy among the conditions Benjamin Davies treats.

CMS data shows 299 Medicare services from Benjamin Davies across 9 procedure codes in 2024, for 172 Medicare patients. Medicare paid $54,348 for them.

CMS counts 172 Medicare patients who saw Benjamin Davies in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Benjamin Davies' median patient age at 69, with 14% women.

In 2024, Benjamin Davies wrote 329 Medicare Part D claims for 91 patients. 95% of them were for generic drugs. CMS names the drug for 245 of them, across 3 drugs with 11 or more claims each, at $2,659 in total drug cost. In 2023, CMS named 325 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Benjamin Davies for performance year 2024, reported as part of a group. Benjamin Davies accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Benjamin Davies as offering telehealth. CMS counts 14 procedures of prostate resection by Benjamin Davies, more than 69% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 291 papers to Benjamin Davies, published from 2006 to 2025. 2019 was the busiest year, with 28. The most frequent topics are Urinary Bladder Neoplasms, Medicare and Prostatic Neoplasms. Benjamin Davies has published most often in Urology. Benjamin Davies' most frequent co-authors are Bruce Jacobs, Mina Fam, MD and Liam Connor MacLeod, MD.

Dmand AI links Benjamin Davies to 2 clinical trials. Conditions studied include Carcinoma, Renal Cell, Prostatic Neoplasms and Kidney Neoplasms.

CMS Open Payments shows 21 general payments to Benjamin Davies from 5 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 82% of the total. Distalmotion US paid the most, $2,255.

Benjamin Davies graduated from Icahn School Of Medicine At Mount Sinai in 2000.

Benjamin Davies is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.